Media Library

A focus on innovation and competitiveness will attract more R&D investments and support the conduct of more clinical trials in Europe.

We must work together to protect the security of medicine supply - learn more about the ways we can ensure this is a reality for all Europeans.

When it comes to orphan and paediatric medicines, a collaborative approach is essential.

A smart and future-proof framework can foster innovation in the EU while ensuring faster and widespread access to medicines.

The EU has an opportunity to ensure that we create a predictable and robust framework that leads to more investments and treatments for patients.

While everyone agrees that better access to medicines is important, the challenge with using the regulatory framework to achieve this objective is that it's not the right tool for the task.

Early signs of spinal muscular atrophy can be subtle, and often go unseen by clinicians – which is why newborn screening is critical to help obtain a prompt diagnosis.

A new, state-of-the-art gene therapy manufacturing facility in North Carolina, USA

Ann describes how to live with symptoms as an adult living with Tuberous Sclerosis Complex (TSC) .

The menace of noncommunicable diseases (NCDs) like cardiovascular disease, diabetes and cancer in the developing world is increasing. New solutions like Novartis Access are needed to ensure more people are trained to prevent, diagnose and treat these diseases, and patients have access to affordable quality medicines.

Welcome to the first-ever Museum of MS, a place that celebrates how people living with multiple sclerosis (MS) overcome the challenges or adapt to the symptoms of MS in their daily lives.

Novartis Access is partnering with the International Committee of the Red Cross to provide access to medicines for Syrian refugees and their host communities in Lebanon.